newsfilter
← Latest News
Business Wire·

Frequency Therapeutics to Participate in 2022 H.C. Wainwright Global Investment Conference

Frequency Therapeutics, Inc. (NASDAQ:FREQ), a clinical-stage regenerative medicine company focused on developing therapeutics to activate a person's innate regenerative potential to restore function, today announced that Chief Scientific Officer Dr. Chr